⌘K
Loading ticker…
Serina Therapeutics, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Serina Therapeutics, Inc. (SER) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.6%, relative volume 0.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
11 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SER is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.7% / -37.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SER is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $244K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $244K |
| VXFVanguard Extended Market ETF | 0.00% | $65K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SER Jan avg: 31.85% median: 31.85% win: 50% σ: 53.80% n: 2 2024-03-28 → 2026-05-29 | SER Feb avg: -19.33% median: -19.33% win: 50% σ: 35.76% n: 2 2024-03-28 → 2026-05-29 | SER Mar avg: 4.05% median: 7.78% win: 67% σ: 12.11% n: 3 2024-03-28 → 2026-05-29 | SER Apr avg: -9.59% median: -6.19% win: 33% σ: 22.78% n: 3 2024-03-28 → 2026-05-29 | SER May avg: 0.64% median: 1.10% win: 67% σ: 5.34% n: 3 2024-03-28 → 2026-05-29 | SER Jun avg: 2.24% median: 2.24% win: 100% σ: 0.61% n: 2 2024-03-28 → 2026-05-29 (current) | SER Jul avg: -7.43% median: -7.43% win: 0% σ: 3.72% n: 2 2024-03-28 → 2026-05-29 | SER Aug avg: -8.24% median: -8.24% win: 0% σ: 6.03% n: 2 2024-03-28 → 2026-05-29 | SER Sep avg: -7.71% median: -7.71% win: 50% σ: 11.96% n: 2 2024-03-28 → 2026-05-29 | SER Oct avg: -2.39% median: -2.39% win: 50% σ: 6.12% n: 2 2024-03-28 → 2026-05-29 | SER Nov avg: -18.91% median: -18.91% win: 0% σ: 5.81% n: 2 2024-03-28 → 2026-05-29 | SER Dec avg: -29.83% median: -29.83% win: 0% σ: 35.73% n: 2 2024-03-28 → 2026-05-29 |